AN INFECTIOUS HEPATITIS OF UNDETERMINED ORIGIN IN MICE : II. CHARACTERISTICS OF THE INFECTIVE AGENT by Jordan, Janet & Mirick, George S.
AN  INFECTIOUS  HEPATITIS  OF  UNDETERMINED  ORIGIN  IN 
MICE* 
II.  C~_~RACr~.lUSTICS Or  ~EE  INr~crrvE  AG~.l~r 
B~  JANET JORDAN,$ M.D., ~  GEORGE  S. MIRICK, M.D. 
WIT~ Tm~ TEcm~cAL ASSlSTANC~  OF M~jomm G. Hucx 
(From the Department of Medicine,  The Johns Hopkins University 
School of Medicine, Baltimore) 
(Received for publication, August 3, 1955) 
The  discovery  of  an  agent  which  produces  transmissible  hepatitis  and 
ascites in mice has been described in a  preliminary report  (1) and in the pre- 
ceding  paper.  It  seems  probable  that  it  was  carried  by  the  strain  of  mice 
under  study. The  disease resembles in  certain respects many known  diseases 
in mice. For this reason, it seemed important to compare this agent point by 
point with a  number  of the  other  known  pathogenic agents  occurring in  the 
O'Grady  strain  of  mice.  Evidence  will  be  presented  that  the  agent  differs 
from  the more  common bacteria,  leptospira, protozoa, rickettsia, and viruses 
known  to  produce  disease in  mice.  It  is  believed  that  the  malady it  causes 
has  not  been  described  previously.  For  convenience  of  discussion  the  agent 
will be  called  ascites  hepatitis  agent  (AHA). 
Agents Studied 
Ascites Hepatitis Agent (AHA).--The strain of AHA first procured by serial passage in 
mice, after an original inoculation with an extract of the liver of a patient (C.B.), was used 
in all the studies described  below. Infectious organ extracts were prepared and  stored as 
described in the preceding paper (2). In many experiments ascitic fluid was also utilized. 
Lymphocytic Choriomeningitis Virus (LCM).--Two strains of LCM virus were compared 
with AHA. One was  strain Armstrong E  350-6 obtained from  the National Type Culture 
Collection.  The Armstrong strain which had been carried through fourteen intraperitoneal 
passages in mice was obtained from Dr. Wallace Rowe at the Naval Medical Research  In- 
stitute. Infective extracts of this virus were stored in tightly stoppered pyrex tubes in the 
dry ice chest. 
Mouse Hepatitis Virus (MHV).--An ampoule containing the lyophilized mouse hepatitis 
virus (MHV) described by Gledhill  and Andrewes (3-5) was provided by Dr. C. H. Andrewes. 
This strain of virus (MI-IV 5841/58)  was maintained by serial, weekly, intraperitoneal pas- 
sage of mouse liver extracts in 2 to 4 gin. suckling mice of the O'Grady or A strains and in- 
fected organs and saline extracts of combined livers, spleens, and kidneys were stored in the 
dry ice chest. 
* These studies were carried out under the sponsorship  of the Commission on Liver Dis- 
ease, Armed Forces Epidemiologieal Board, and were supported in part under contract with 
the Office of Naval Research. 
~t Fellow of the National Foundation of Infantile Paralysis, Inc. 
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EXPEI~  ]7~NTAL 
Characteristics of AHA 
The  Virulence  of AHA.--The  virulence of AHA was difficult to quantitate 
because of the generally mild character of the infection and its low mortality. 
On  many occasions  serial  tenfold  dilutions  of organ  extracts or ascitic  fluid 
in 0.85 per cent saline or in trypticase soy broth were inoculated intraperito- 
neally into mice. The infectivity titer of fresh 10 per cent organ extracts was 
usually 10  -2 and on a few occasions 10  -8. Dilutions greater than this were never 
infectious.  No  detectable  increase  in  virulence  occurred  during  14  serial 
monthly passages after the disease was first recognized. 
TABLE I 
The Effect of Storage at -70°C. on the Infectgvity of Ascites Virus of Mice (AHA) 
Virus preservation 
Used fresh 
CO2 chest, 1 day-2 mos. 
Cfh chest, 2 mos.-5 mos. 
Total. 
No. of 
experi- 
ments 
6 
6 
11 
23 
Total No. 
of mice 
130 
141 
433 
704 
Signs of infection in mice 
.Mcites 
No.  Per cent 
60  46 
44  31 
74  17 
178  ]  25 
Hepatitis 
No.  Per cent 
109  84 
73  52 
2O9 
391  56 
The Stability  o/AHA.--A single  quick  freezing  of AHA  suspensions  in  a 
dry ice-alcohol mixture with thawing on the subsequent day usually resulted 
in a tenfold fall in infectivity titer. Quick freezing and thawing ten times com- 
pletely destroyed its infectivity. The effects of storing the agent in a  dry ice 
chest of -70°C. for various periods are shown in Table I. It will be seen that 
the  average incidence  of hepatitis  and  ascites  decreased  markedly within  a 
few  months.  Hepatitis  with  ascites  occurred  in  46  per  cent  of  inoculated 
mice when freshly harvested virus was used,  in 31  per cent after storage in a 
dry ice chest for one day to 2 months, and in 17 per cent after 2 to 5 months' 
storage. The incidence of hepatitis without ascites in the inoculated mice was 
84 per cent, 52 per cent,  and 48 per cent respectively. Ascites was never ob- 
served in the absence of hepatitis. 
The infectivity of some virus preparations resisted storage for over 6 months 
in the dry ice chest at  --70°C.  In several experiments aliquots of virus were 
stored  at  several  temperatures  for various  times.  These  aliquots  were  then 
compared for infectivity, as  summarized in  Table II.  Although  the  number 
of animals inoculated was small, it seemed from the findings that storage in an 
electric deep freeze at about -12 ° was less effective than in the dry ice chest. 
This was surprising  since  some preparations of the virus remained  infective JANET JORDAN  AND  GEORGE  S. MIRICK  619 
for at least 4 months at 4°C. Infectivity was practically destroyed by heating 
virus  suspensions  at  60°C.  or  more for  1  hour,  and  was  greatly  decreased 
by 56°C. for 1 hour. 
Five attempts were made to preserve the virus by drying it in the frozen 
state. In no instance did this lyophilized material result in unequivocal infec- 
tion. 
Hydrochloric acid (4 N) was added to some aliquots of infective organ ex- 
tracts in amounts sufficient to bring the pH to 1, and sodium carbonate solu- 
tion to others to make the pH 9.  Mter 4 hours at 4°C.  the normal pH, 6-7, 
was  reconstituted  and  mice  were  inoculated.  Both  treatments  resulted  in 
decreased infectivity, but not in complete loss. 
TABLE II 
Effect of Temperature on lnfeah~ity of AlIA 
No. of 
experiments 
1 
3 
4 
Total 
Time 
1hr. 
3 days 
3 wks. 
2-3 mos. 
4-6  " 
--7ooc. 
m 
3/3/3 
1/2/2 
13/12/17 
5/8/15 
22/25/37 
Temperature 
--12°C. 
m 
0/1/9 
2/3/11 
2/4/20 
+4°C. 
lO/lO/lO 
3/3/3 
51 51 7 
31 3/4 
21/21/24 
+56°C. 
2/6/13"  c/2/7 
+1~°C, 
o/3/13 
* The first number represents  the  mice with  ascites;  the  second  the  mice with  helm" 
tosplenomegaly,  and  the third  the total inoculated. 
Sire of AHA.--Though  the actual size of AHA has not been determined, 
it would seem to be considerably larger than most viruses. Filtration through 
Whatman paper 2, which held back most of the cells, did not seem to diminish 
the  infectivity of organ extracts or of ascitic fluid, but  the filtration of ex- 
tracts or ascitic fluid through a single Seitz pad removed infectivity as several 
such  tests made plain.  Only the  sediment was  infective after centrifugation 
of  these  materials  at  13,000  R.1,.~t. for 30  minutes.  Centrifugation  at  only 
2500 R.1,.~. for 20 minutes yielded equivocal findings but when it was done at 
this speed for 1 hour the infectivity was concentrated in the sediment. How- 
ever, these findings should be viewed in the light of the fact that the materials 
were of such low infectivity. Even the relatively small pneumonia virus of mice 
(PVM)  (6) will give similar results when strains of low titer are tested (7). 
Failure  of AlIA  to Agglutinate  Erythrocytes.--Numerous  fruitless attempts 
were made to produce hemagglutination of erythrocytes with AHA. Infective 
ascitic fluid and organ brei were compared with normal tissue bre/, fresh and 
after heating at 56  ° or 65  ° for 1 hour. The washed erythrocytes of mice, ham- 
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tested,  and  the  tests  were  made  both  at  room  temperature  and  4°C.  and 
were read at various intervals for  12 hours. In no case was hemagglutination 
obtained in higher titer than with normal tissue extracts.  If AHA can cause 
the agglutination of erythrocytes it must be with cells from other species or 
by other techniques than those utilized. 
TABLE HI 
Effect of AntffaicrobiaI Agents on AHA Infection in Mice 
Drug 
gulfadiazine. 
Penicillin.. 
c¢ 
c¢ 
['enicillin 
tl 
~t 
t¢ 
%ureomycin  ..... 
terramycin  ...... 
Streptomycin. 
Daily Dose 
10 mg. 
100 units 
cc  ¢¢ 
A d libitum 
100 units 
A d libiturn 
I rag. 
25 mg. 
500 units 
Route 
Per os 
Subcutaneous 
¢c 
Per  os 
Subcutaneous 
Intrapetitoneal 
Per os 
Subcutaneous 
Per os 
Subcutaneous 
Time in 
days 
0-28 
0-1 
0-7 
7-14 
14--21 
0-28 
14-28 
0-28 
0-28 
24-32 
0-28 
0-28 
No. of 
Exits. 
Results 
Treated  Controls 
31 415'  21 216 
s/5/5 
s/4/s  5/s/s 
5/5/s 
41 41 s 
9/13/'16  10/12/12 
8110112  61 s/io 
o/0/8  5/6/6 
9/13/19  12/14/14 
2/ 3/ 3  1/ 4/ 6 
s/5/8  2/2/6 
31418  31718 
* Scoring as in Table II. 
The Effect of Antimicrobial Agents on AlIA  Infection 
Several  antimicrobial agents  were  tested  separately  for  their  effects  on 
AHA infection.-- 
Sodium stdfadiazine was given to inoculated mice as a 0.1 per cent solution in the drinking 
water for 1 week after inoculation but then discontinued because of its toxicity. The water 
Supplied these mice did not contain any urethane. The other drugs tested were given through- 
out the whole month from the day of virus inoculation until the time of sacrifice. Some mice 
were provided ad b/b/turn  with an aqueous sointion of penicillin G containing 50 units per cc. 
Others were given penicillin G subcutaneously in a dose of 100 units/mouse/day  in one or two 
divided injections. Aureomycin hydrochloride, I  reg./mouse  once daily, was injected  sub- 
cutaneously in a saline sointion containing 5 per cent gum acacia. Other mice received a 0.25 
per cent aqueous solution of terramycin  to drink. Streptomycin, 50 units/mouse/day, was 
injected in 2 divided doses into yet other mice. 
The results of  these  experiments are  sumraarized in Table III. It will be 
seen  that  none of  the  drugs  tested  seemed  to  have  any inhibiting influence JANET JORDAN AND GEORGE S. MIRICK  621 
upon the infection, with the possible exception of penicillin. However, ascitic 
fluid taken from mice treated with penicillin subcutaneously for 12 days prior 
to paracentesis proved infective on test. 
Cortisone,  0.25  reg./mouse/day,  injected  subcutaneously,  did  not  affect 
the  infection rate  when given during the  first  2  or  the  last  2  weeks  of  the 
incubation period.  It  may  have  had  some  effect  to  lessen  the  ascites  and 
hepatosplenomegaly when given for 4 to 11 days after ascites appeared. 
Tests for the Presence  in the Blood of Protective Antibodies against AlIA 
The absence of immunity in mice convalescent from the hepatitis to rein- 
fection with  AHA  has  been reported  in  the  preceding paper.  Furthermore, 
TABLE IV 
Attempts to Neutralize AHA Infection Ioltk Specific Sera 
Serum 
None .............................. 
Normal mouse pool ................. 
Convalescent mouse pool ............. 
Normal rabbit  ...................... 
Anti-mouse rabbit  ................... 
Anti-AHA rabbit ................... 
"liter of extract 
10-1  10-1  I0  -2 
315/6" 
1/112 
2/2/3 
1/2/3 
2/3/3 
21313 
1/2/6 
11113 
01113 
2/2/3 
2/313 
01113 
0/0•6 
o/1/3 
0/0/3 
01013 
011/3 
0•2/3 
* The results axe recorded as explained under Table IL 
it was found that blood collected during  the ascitic phase of the disease and 
extracts  of  the  organs,  as  obtained  up  to  6  months  after  inoculation,  were 
both  infective.  Nevertheless  attempts  were  made  to  neutralize  AHA  with 
the sera of convalescent mice or of rabbits injected with the agent. 
Blood from normal mice and from mice 1 to 2 months after recovery from aseites was col- 
lected, pooled, and the serum separated. Normal rabbit sera and the serum from  7 rabbits 
injected with extracts of livers, spleens, and kidneys from mice that had come down with the 
disease were also coUected. Four of the rabbits haxi been given 1 co. of a 10 per cent extract of 
infective organs intravenously and two had been injected subcutaneouly with a mixture con- 
sisting of about 0.2 cc. each of such an organ extract and falba, and 0.1 cc. of mineral oil. 
An additional rabbit had received 9 intravenous injections over a 3 week period, altogether 18 
ee. of a 10 per cent extract of liver-spleen-kidney  brd from normal mice. 
In aU these instances the serum tested was obtained about 1 month after the last injection. 
Tenfold dilutions of 10 per cent AHA extracts were mixed with equal quantities of the tin- 
diluted sera, and allowed to stand for 12 hours at 4°C. Normal mice were then inoculated 
intraperitoneally with 0.2 of the mixtures. 
The results  are shown  in  Table IV.  It will  be seen  that  none  of the  sup- 
posedly immune sera  effected  any definite neutralization of  the  agent.  The 
numbers of  mice  employed  were  too  small  for  quantitative interpretation, 622  AN  IN]~ECTIOUS  HEPATITIS  OF  UNDETE]~MINED  ORIGIN.  II 
but the presence of mice with ascites and hepatitis in the groups given "im- 
mune" serum mixtures, excludes the presence of large quantities of protective 
antibodies. However, complement-fixing antibodies were found to be present 
in AHA convalescent sera as will be described below. 
Attempts to Identify AlIA 
Among the many diseases indigenous in mice, only a  few produce a  patho- 
logical picture closely resembling that of the disease we have described. Ex- 
tensive and intensive efforts were made to identify AHA infection, with some 
one of the maladies already known. The results of these efforts will now be 
reported. 
The Microscopic Examination  of  Tissues.--Hematoxylin  and eosin--stained 
sections of the liver, spleen, brain, kidney, lung, heart, and ascitic fluid sedi- 
ment failed to reveal evidence of bacteria, fungi, protozoa, or inclusion bodies. 
Giemsa-stained slides of liver, brain,  spleen,  and ascitic fluid sediment were 
hkewise negative. No intranuclear or intracytoplasmic inclusion bodies were 
ever noted in our laboratory. Gram stains of the tissues showed no bacteria. 
However, Dr. Anthony Morris  (8)  of the Army Medical School has demon- 
st.rated on several occasions with Giemsa stain the presence of pink-staining 
pleomorphic inclusion bodies in the nucleus or cytoplasm of occasional cells in 
ascitic fluid sediment and splenic pulp  from a  strain of mice infected with 
AHA. The identity of these bodies is uncertain, as is their relationship to the 
disease under study. It has been considered that they may represent a  pro- 
tozoan. 
Bacteriological  Cultures  of  the  Extracts  Containing  AHA.--Cultures  of 
ascitic fluid and organ extracts from mice infected with AHA were done re- 
peatedly. As routine, Brewer's thmglycollate medium and trypticase soy agar 
plates containing 10 per  cent human blood were inoculated with these ma- 
terials.  Plates  were  incubated both  aerobically and  under  anaerobic  condi- 
tions.  Infective ascitic fluid usually proved  to be  sterile but  the organ brd 
always was found to contain a  few miscellaneous bacteria whenever a  large 
inoculum was cultured. Staphylococci, diphtheroids, or Bacillus  subtilis  were 
usually found but their presence seemed unrelated to  the infection. The in- 
testinal flora from the large bowels of infected mice was cultured on blood 
agar plates and desoxycholate citrate agar (Baltimore Biological Laboratory). 
No  relation was found between the  species  of organisms thus cultured and 
the susceptibility of the mice to AHA. On  several occasions cultures of the 
organ  extracts  or  intestine yaelded Salmonella  typkimurium.  These  infected 
preparations were not used for passage,  and no  epizoofic  due to  that bac- 
terium developed in the mice. 
The signs typical of infection with pleuropneumonla-like organisms, namely 
rolling and  polyarthritis  (9-11),  were  never  observed  in  our  mice.  Special JANET  JORDAN AND  GEORGE S.  MIRICK  623 
cultures for pleuropneumonia-like organisms were made on agar plates enriched 
with 20 per cent human ascitic  fluid  (12). No strains of this organism  were 
recovered  from AHA infected mice,  even though the media employed  were 
found on test to sustain the growth of 5 typical strains of this organism ob- 
tained through the courtesy of Dr. Harry Morton of the University of Pennsyl- 
vania. It was concluded  that the infection was not caused by any bacterium 
known to be pathogenic for mice. 
Comparison of AlIA with Leptospira.---The  infection of mice with leptospira 
has been reported (13-15) but the resulting  changes are not like those of the 
disease we have described. Nevertheless,  a search, which proved fruitless, was 
made with the darkfield microscope for these organisms in infective  extracts 
and ascitic  fluid.  Cultures of such  materials proved sterile  on  the medium 
recommended by Gardner (16) for growing leptospira.  In the pooled sera from 
normal mice or from acutely infected or convalescent  mice, Dr. Paul Beeson 
found no agglutinins against 8  strains of leptospira  (L. ballum, L.  canicola, 
L.  grippotypkosa,  L.  hebdomadis-T.,  L.  iaeroheraorrhagiae, L.  sackoeblng, L. 
pomona, and L. raitis). 
It is concluded that AHA is not one of these leptospira. 
Comparison of AlIA witk Protozoa.--Infection  of mice with encephalitozoon 
or toxoplasma  may result in a disease generally resembling that due to AHA 
(17, 18). However, Giemsa-stained sections from the brains of mice with typi- 
cal AHA infection did not show the curved rods in round cyst-like accumula- 
tions, within cells or at the margin of inflammatory lesions, which are typical 
of encephalitozoon  infections in mice. Also brain sections from AHA-infected 
mice showed no meningoencephalitis  (which is present in over 90 per cent of 
mice infected with encephalitozoon),  and none of the extracellular  parasites 
typically seen in toxoplasmosis.  Failure to infect rabbits with AHA further 
differentiates it  from  encephalitozoon.  Toxoplasma,  unlike  ALIA, does  not 
survive  storage  with dry ice. As stated previously,  inclusion bodies possibly 
protozoan have been  demonstrated in some mice infected with AHA by Dr. 
Anthony Morris (8) but the relation of these to the disease is not certain. 
Comparison of AHA witk Rickettsia.--No  disease in mice due to rickettsia 
has been described which produces  the obvious signs or pathological  features 
of AHA infection. Yet the possibility  that AHA is an agent in this group of 
microorganisms  has not been  excluded.  However,  this  seems  unlikely since 
no rickettsia have been  seen after appropriate staining of infected  material, 
nor has infection been established  in the yolk sac of embryonated hens' eggs 
(2). Serological tests to exclude the known rickettsia were not made. 
Comparison of AlIA witk the Known Viruses of Mice.--A number of viruses 
may be carried  by mice. AHA differs strikingly from some of these,  namely 
PVM  (19), GDVII (20), and ectromelia  (21, 22), in its strict viscerotropism 
and its failure  to agglutinate erythrocytes. Members of the psittacosis  group 624  AN  INFECTIOUS  HEPATITIS  OF  UNDETERMINED  ORIGIN.  H 
seem to be further excluded by the general absence of intraceUular inclusion 
bodies, the failure to infect embryonated eggs, and by the fact that the sera 
from 6 rabbits immunized against AHA failed to fix complement with lygranum 
antigen  (obtained from E. R. Squibb and Company). 
Various workers have reported  the  occurrence of hepatic  lesions in  other- 
wise healthy mice. Olitsky and Casals (23)  described infiltration and necrosis, 
and acidophilic intranuclear inclusion bodies, in the livers of supposedly nor- 
mal mice of the  Rockefeller  Institute  strain,  especially with  increasing  age. 
Pavilanis and Lepine (24), Findlay (25), Nicolau and Ruge (26), and Gledhill 
and  An&ewes  (3)  have  described  similar  inclusion  bodies  in  the  livers  of 
mice of other strains.  The agent responsible for these bodies was thought  to 
be a virus, and in some instances the condition characterized by them seemed 
to be transmissible, but in no case did obvious signs of illness result.  Careful 
search for inclusions  in  the appropriately stained  liver cells of mice infected 
with AHA failed to disclose any like those described in the literature. 
Comparison of AlIA with "Mouse Hepatitis  Virus" (MliV)  of Gledhitl and 
Andrewes.--Gledhill  and Andrewes  (3-5)  described  a  transmissible  hepatitis 
in  suckllug  mice  that  proves fatal. A  specimen of  this  agent  was obtained 
from Dr. Andrewes  and  its  effects compared  with  those of AHA  in several 
strains of mice. 
These agents caused focal liver necrosis and death within 6 to 10 days in nearly all 2 to 4 
gin. mice of our strains. In similar mice, AHA caused typical non-fatal disease with an incuba- 
tion period of about 2 weeks. Infection with MHV, imlil~e AHA infection, resulted in livers 
covered with light spots which later coalesced to involve nearly the whole liver. There was no 
ascites. However, the hepatic changes in the two infections were indistinguishable histologi- 
cally. As in the case of AHA, chronic carriers of MI-IV  have been reported, and mice convales- 
cent from MHV infection developed no protective circulating antibodies, or these only in low 
titer. It was impossible to test convalescent immunity to MHV infection since weanling mice 
of the strains we employed proved naturally resistant. Since mice of all ages are susceptible 
to AHA infection it was decided to challenge MHV convalescent  mice with AHA. It was found 
that 5 gm. mice  which had survived infection with MHV were as susceptible as normal ani- 
mals to infection with AHA. Also, weanling mice inoculated with infectious MHV proved 
susceptible to subsequent infection with AHA. Conversely, litters of mice convalescent from 
AlIA infection were susceptible to MHV. 
These  findings  are  not  surprising  since  AHA  infection  does  not  result  in 
homologous immunity  (2)  and MHV infection produces protective antibody 
only in low titer (3). It seems evident that no relationship between these two 
agents can be demonstrated on immunological grounds.  Moreover differences 
in their size,  the incubation periods of the diseases they produce,  the  course 
of  their  diseases,  and  a  differing age susceptibility  of inoculated  mice  serve 
thus far to distinguish them. 
Comparison of AHA  with the Acute Hepatitis  Virus  of Nelson.--The  viral 
hepatitis  of  mice  described  by  Nelson  (27,  28)  in  association  with  mouse JANET ,]'ORDAN AND  GEORGE  S.  MIRICK  625 
leukemia  is  also characterized  by absence of immunity.  This  disease differs 
from  AHA infection  in  its  short  incubation  period,  the  absence  of ascites, 
and  the  relatively high  mortality  in  weanling  mice.  Pathologically,  marked 
liver cell necrosis  without perivascular cuffing is noted. Moreover, the agent 
unlike AHA is present in the urine readily filterable,  transmissible orally; and 
is present in high titer. 
Comparison of AHA with Lymphocytic Choriomeningitis (LCM).--The virus 
of  lymphocytic choriomeningitis  (LCM)  is  carried  by mice,  and  some vis- 
cerotropic strains may produce signs in  these animals  which closely resemble 
those of infection  with AHA (29, 30). The failure of AHA to cause meningitis 
TABLE V 
Attempts  to  Neutralize AHA  and  Neurotr~ ~  LCM with Rabbit and  Guinea Pig Antisera 
Method 
Intracutaneous 
t4 
Serum 
None 
Anti-AHA rabbit 
Anti-LCM guinea pig 
Anti-LCM guinea pig 
None 
Intraperitoneal 
ct 
Virus Dilution 
Virus 
0  I0  -1  10 "~  10-t  10-4 
LCM  3/3*  2/2  1/3 
LCM  0/2  4/4  4/4  0/4 
LCM  0/2  0/4  0/4  0/4 
AHA  0/2  8/8/8~ 
AHA  7/7/7 
I0-I 
0/3 
o/4 
o/4 
* Numerator,  number  of mice dying in  opisthotonos;  denominator,  number inoculated. 
:~ First digit, mice with ascites; the second digit, mice with hepatosplenomegaiy; the third 
digit, number inoculated. 
in  mice  after  intracerebral  inoculation,  or  to  infect  embryonated  eggs  or 
guinea pigs,  suggested that  it differed  from LCM. However, cross-serological 
and  cross-immunity  experiments  were  indicated  to  settle  this  point.  The 
failure  of anti-LCM  sera  to  neutralize  AHA  infection  has  been  mentioned 
above and is shown in Table V. Nevertheless attempts were made to neutralize 
LCM virus in vitro using  serum from rabbits previously injected with AHA, 
and  to neutralize AHA with anti-LCM guinea pig serum of known potency. 
Ten per cent brain extracts containing LCM  (Armstrong E  350-6)  were diluted serially 
in trypticase soy broth and then mixed with equal volumes of the sera to be tested. These 
mixtures were allowed to stand for 1 hour at 4°C., and then mice, lightly anesthetized with 
ether, were inoculated intracerebrally with about 0.03 cc. of each virus-serum mixture. Those 
which died with opisthotonos 5  to  12  days after inoculation were considered to have suc- 
cumbed to the virus. 
In the intraperitoneal tests with AHA similar agent-serum mixtures were made and each 
mouse infected intraperitoneally with 0.2 cc. The mice were sacrificed  1 month later and ex- 
amined for evidence of disease. 
The results of these tests are summarized in Table V. It will be seen that 
the  neurotropic  LCM  virus  was  completely  neutralized  by  the  anti-LCM 626  AN  INFECTIOUS  E[EPATITIS  OF UNDETERMINED  ORIGIN.  II 
guinea pig serum,  within the  limits tested,  but its titer was  not decreased  at 
all by the anti-rabbit serum. The anti-LCM guinea pig serum failed to  cause 
neutralization or  decreased  severity of AHA  infection by the  intraperitoneal 
route. 
Tests for protective antibody against LCM were carried out on two pools of serum obtained 
from patients preceding and 3 weeks following AHA inoculation. These were done by Dr. 
Wallace P. Rowe at  the Naval Medical Research Institute (NMRI), using the technique 
described by him for the demonstration of protective antibody in LCM immune mice (31). 
The results are shown in Table VI. 
TABLE VI 
Attempts  to Protect Mice with Mouse Sera againsS Vi~cerotrophlc St¢ain  of LCM  Virus 
Experiment 
No.  Mouse serum pool 
Anti-AHA  8 wks. 
Normal (O'Grady) 
Anti-AHA  8 wks. 
Normal (O'Grady) 
Anti-LCM  13 days 
(NMRI mice) 
Anti-LCM  20 days 
(NMRI mice) 
Normal (NMRI) 
Recipient mice showing 
more than O. 15 ml. fluid 
Thorad_._.__~c  Tota_.___~l 
5/16"  5/16 
s/9  719 
5/20  7/20 
11/19  12/20 
3/15  3/15 
6/16  8/16 
11/16  12/16 
Probability 
Thor~ci.......___~c  __ 
o.os~; 
0.01 
0.01 
0.01 
Total 
0.01 
0.05 
0.01 
0.02 
* Thoracic plus peritoneal fluid. 
Numerator, number of mice showing more than 0.15 ml. fluid. Denominator, number of 
mice injected. 
The sera were inactivated by heating at 54--56°C. for 30 minutes, and 0.1 ml. was inoculated 
intraperitoneally  into each of a group of 9 to 20 normal 5 to 6 week old mice of the NMRI stock. 
4 or 24 hours later e~zh mouse was inoculated intraperitoneaUy with 0.1 ml. of a dilution of 
Armstrong strain LCM-infected mouse spleens, containing approximately 100 IDa0 of virus 
per inoculum. On the llth day after infection the mice were sacrificed by ether inhalation and 
the volume of fluid in the thoracic and peritoneal cavities was measured with a 1 ml. pipette. 
Mice dying before the day of sacrifice were autopsied to learn whether fluid was present. The 
results of the two experiments carried out by this procedure are shown in Table VI. These 
results indicate that, under the conditions tested, mice convalescent from AHA infection de- 
veloped circulating substances which provided partial but significant protection against the 
viscerotropie strain of LCM virus, and that the protection observed was of a  comparable 
order to that produced by LCM-immune mouse serum in the same experiment. For reasons 
stated above, AHA was thought to differ from LCM but the immunological data of the table 
imply  antigenic  simllarities  between the two agentsor else that some of the mice employed had 
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Further  tests,  using  a  standard  complement  fixation  technique,  were  also 
carried out by Dr. Wallace Rowe. 
A pool of sera from mice which had been infected with AHA was tested with 9 separate 
antigens prepared from mouse livers or spleens infected with LCM and chick embryos infected 
with LCM. A standard anti-LCM guinea pig serum fixed complement, in titers of 1:2 to 1:16, 
with all these antigens. The anti-AHA mouse serum pool likewise fixed complement with 6 
of the 9 antigens to a titer of about 1:5. This pool also fixed complement with two homologous 
antigens prepared from the liver and spleens respectively of mice infected with AHA, but the 
anti-LCM guinea pig serum did not fix complement with these two heterologous antigens. 
The  results  of  these  complement  fixation  tests  further  support  the  belief 
that  LCM  and  AHA, though  possibly related  immunologically, are distinct. 
TABLE VII 
Titration of LCM in Mice Previ,  ou~ly Infected with AHA 
Time after 
inoculation 
with AHA 
4 wks. 
6-10 wks. 
Dilution of LCM virus inoculated  intracutaneously 
Stage of hepatitis 
....  10-__~l  I0-*  I0~  10-~  10~ 
0  3/3  2/2  1/3  0/3  0/3 
Acute  2/2  2/2  2/2  J  0/2  ]  0/2 
Convalescent  ]  2/2  13/3  i  2/2  [0/3  [  0/4 
Scoring: 
number dying in opisthotonos 
total number of mice inoculated" 
Finally, tests were done to determine the susceptibility of mice, convalescent 
from  AHA infection  to  challenge with LCM. 
The absence  of solid homologous immunity to AHA infection  has been reported above. 
However, mice convalescent  from intraperitoneal infection with LCM develop immunity to 
subsequent intracerebral challenge with that virus (25). The neurotropic strain of LCM was 
titered in three groups of mice  intracerebrally, by the method previously described.  One 
group had acute AHA infection at the time of LCM inoculation; a second group was convales- 
cent from AHA infection  (6 to 10 weeks); and a third group consisted of -nlnoculated mice 
of about the same age. The results are shown in Table VII. 
It will be seen  that  the AHA-infected and  convalescent mice  were just as 
susceptible as controls to challenge with LCM. 
The  immunological  and  cross-immunity  data  just  set  forth  support  the 
belief that AHA and LCM  are separate entities. Some of these data suggest, 
however,  that  there  may  be  an  immunological  relationship  between  AHA 
and the viscerotropic strain of LCM. 
RECAPITULATION  AND  DISCUSSION 
The disease seen in mice inoculated with the agent we have called AHA has 
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infection but a search for pathogenic bacteria,  leptospira,  protozoa,  rickettsia, 
and viral inclusion bodies has yielded only negative findings in our laboratory. 
The demonstration by Dr.  Anthony Morris  of intranuclear and cytoplasmic 
inclusion bodies suggests that a  protozoan  may occur in mice infected  with 
AHA.  In  this  connection  it  is  of  interest  that  Eperythrozoon  coccoides  in- 
creased the virulence  of the mouse hepatitis virus (MttV--S  component)  as 
described by Niven et al.  (5), and by Nelson  (32). 
The failure  to filter  AHA and  the fact that  it is  sedimented  readily by 
centrffugation  make it unhkely that the agent is a filterable virus.  However, 
the possibility  that even  a  small virus of low  titer might have these char- 
acteristics,  and our failure  to demonstrate any known agent, required  that 
its possible viral identity be considered. The physical and pathological findings 
in mice infected with AHA were similar in some respects to those in mice in- 
fected  with  lymphocytic  chofiomeningitis  virus  (LCM),  with  the  mouse 
hepatitis virus (MHV) of Gledhill and Andrewes, and with the acute hepatitis 
virus of mice described by Nelson. Efforts were made to obtain positive  evi- 
dence of its possible relationship  to these agents. Its chief points of distinction 
from LCM are the longer incubation period of AHA, its failure to cause men- 
ingitis  in mice inoculated  by the intracerebral  route, and its failure  to infect 
guinea  pigs  and  embryonated hens'  eggs. However,  strains  of  LCM  have 
been encountered  with differing potentials in each of these respects.  For this 
reason the certain differentiation  of AHA from LCM seemed to depend upon 
the demonstration of antigenic  dissimilarities.  It was found that both neu- 
tralizing and complement-fixing antibodies against LCM appeared  in the sera 
of mice  convalescent  from AHA infection.  However,  anti-LCM guinea  pig 
sera  did  not  protect  against AHA  infection  or  fix complement  with AHA 
antigens which were active in the homologous system. More important, mice 
convalescent  from  AHA  infection  manifested no  resistance  on  subsequent 
infection with LCM. These differences, together with those noted previously, 
are considered sufficient to distinguish  these  two agents.  The appearance  of 
anti-LCM antibodies in mice convalescent from AHA infection suggests either 
some antigenic crossing between these agents or that some of the mice of the 
strain  employed  might carry LCM virus.  Further  experimentation will be 
necessary to settle these points. 
AHA shares  certain characteristics  with MHV (3-5)  and the mouse hepa- 
titis virus  described  by Nelson  (27, 28). It  is  probably identical  with  the 
hepatitis agent described  by Lackey et  al.  (33). Most striking  are  the pre- 
dilection  of  all  these  agents  for  the  livers  of  mice.  Occasionally  there  is 
similarity of  the  histopathological  pictures  in  the  livers  following each  in- 
fection.  However,  AHA usually results  in more  marked cellular  infiltration 
and less necrosis  than has been  seen with the other agents.  Moreover,  ho- 
mologous protecting antibodies  do not develop or only in low titer following JANET JORDAN AND GEORGE  S. MIRICK  629 
each of the diseases. The points of difference are striking. It has been shown 
that mice of all strains and all ages tested are susceptible to AHA infection 
but with practically no mortality. In contrast MI-IV is reported to infect only 
suckling mice,  or  in  addition weanling mice  of one  strain  (BSVS),  and  in 
susceptible  mice it  is  highly fatal.  The  mouse  hepatitis virus  described by 
Nelson produced death in 98 per cent of Princeton weanling mice but in only 
4 to 12 per cent of mice of other strains. AHA infection resulted in negligible 
mortality in all strains and ages of mice tested and had a  considerably longer 
incubation period  than  that  described  in  the  other  diseases except  that re- 
ported by Lackey et al.  (33).  The agents of both of these diseases have not 
been demonstrated to pass through a Seitz filter. 
SUMMARY 
A transmissible agent (AHA) causing ascites and hepatitis in mice has been 
described. No known pathogenic bacteria, fungi, protozoa, leptospira, rickett- 
sia, or viruses have been  demonstrated in  the  infected mice. AHA does not 
pass through a  Seitz filter and differs in most respects from the agents previ- 
ously described which produce hepatitis in mice. 
We wish to acknowledge  the valuable  technical  assistance of Mrs. Marie Maselba~  and Mr. 
John Lockner. 
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